Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway | Journal of Experimental & Clinical Cancer Research | Full Text

Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway | Journal of Experimental & Clinical Cancer Research | Full Text

Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway

An amendment to this paper has been published and can be accessed via the original article.

Authors:Jing Zhang, Xiao-han Liu, Cong Li, Xiao-xing Wu, Yan-lin Chen, Wen-wen Li, Xian Li, Fan Gong, Qin Tang and Dan Jiang

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:115

Content type:Correction

 

Published on: 17 June 2020

The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:79

• ViewFull Text
 
• ViewPDF